Zhang and fellow students are benefiting from enhanced skill development as a result of a new type of position at the School, called the PCE core faculty.

First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively ...

The brain is one of the body’s most energy-demanding organs, accounting for 2 percent of the body’s weight but consuming 20 ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...

The ubiquity of love across societies and its endurance across millennia is likely rooted in something basic and primal to human nature, Schwartz and Olds say. While it’s unclear whether being head ...

In a small clinical trial of nine patients with advanced kidney cancer, a personalized vaccine generated robust immune response. All patients remained cancer-free for an average of 3 years. The ...

At a glance: Biochemical analyses provide an answer to the question of how the gut bacterium Morganella morganii might contribute to some cases of major depressive disorder. Incorporation of an ...

At a glance: Study explains long-standing question of why Huntington’s disease symptoms typically do not appear until midlife even though patients are born with the mutation. Analyses reveal that the ...

Gary Ruvkun, professor of genetics at Harvard Medical School and an investigator at Massachusetts General Hospital, has received the 2024 Nobel Prize in Physiology or Medicine for the discovery of ...

New AI model identifies possible therapies from existing medicines for thousands of diseases, including rare ones with no current treatments. The AI tool generates new insights on its own, applies ...